Quick answers
- What is Orphenadrine citrate, aspirin and caffeine used for?
- The FDA-approved label (Norgesic, Galt Pharmaceuticals, LLC, January 8, 2026) says: “Norgesic TM (orphenadrine citrate, aspirin and caffeine 25 mg/ 385 mg/ 30 mg) Tablets are indicated in: Symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. The orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- What are the side effects of Orphenadrine citrate, aspirin and caffeine?
- The “Adverse Reactions” section of the FDA label (Norgesic, Galt Pharmaceuticals, LLC, January 8, 2026) begins: “Side effects of Norgesic TM Tablets are those seen with aspirin and caffeine or those usually associated with mild anti-cholinergic agents. These may include tachycardia, palpitation, urinary hesitancy or retention, dry mouth, blurred vision, dilation of the pupil, increased intraocular tension, weakness, nausea, vomiting, headache, dizziness, constipation, drowsiness, and rarely, urticaria and other dermatosis.” … This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Orphenadrine citrate, aspirin and caffeine have a boxed warning?
- No. None of the 5 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Orphenadrine citrate, aspirin and caffeine?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from November 13, 2026).
- Has Orphenadrine citrate, aspirin and caffeine been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Orphenadrine citrate, aspirin and caffeine?
- 3 companies list prescription products of Orphenadrine citrate, aspirin and caffeine in the FDA NDC Directory, including Galt Pharmaceuticals, LLC, Atland Pharmaceuticals, LLC and Poly Pharmaceuticals, Inc.
What Orphenadrine citrate, aspirin and caffeine is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Norgesic TM (orphenadrine citrate, aspirin and caffeine 25 mg/ 385 mg/ 30 mg) Tablets are indicated in: Symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. The orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. …
— FDA label: Norgesic, Galt Pharmaceuticals, LLC, effective January 8, 2026. Read the full label on DailyMed →
Label quoted: the one for the most common form (tablet, oral), Norgesic, Galt Pharmaceuticals, LLC; it covers 1 product in the FDA NDC Directory. The side effects, interactions, dosage and pregnancy quotes below come from this same label.
The FDA has 5 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 5 FDA labels for this medicine have a boxed warning.
Orphenadrine citrate, aspirin and caffeine side effects
Quoted from the “Adverse Reactions” section of the FDA-approved label. Tell your doctor about any side effect that worries you.
Side effects of Norgesic TM Tablets are those seen with aspirin and caffeine or those usually associated with mild anti-cholinergic agents. These may include tachycardia, palpitation, urinary hesitancy or retention, dry mouth, blurred vision, dilation of the pupil, increased intraocular tension, weakness, nausea, vomiting, headache, dizziness, constipation, drowsiness, and rarely, urticaria and other dermatosis.
Read more of this section
Infrequently, an elderly patient may experience some degree of confusion. Mild central excitation and occasional hallucinations may be observed. These mild side effects can usually be eliminated by reduction in dosage. One case of aplastic anemia associated with the use of orphenadrine citrate, aspirin and caffeine has been reported. No causal relationship has been established. Rare G.I. hemorrhage due to aspirin content may be associated with the administration of Norgesic TM Tablets. Some patients may experience transient episodes of light-headedness, dizziness or syncope.
— FDA label: Norgesic, Galt Pharmaceuticals, LLC, effective January 8, 2026. Read the full label on DailyMed →
Orphenadrine citrate, aspirin and caffeine dosage
Quoted from the “Dosage and Administration” section of the FDA-approved label. Your own dose is the one your doctor prescribes: do not change it on your own.
Norgesic TM Tablets: Adults 1 to 2 tablets 3 to 4 times daily.
— FDA label: Norgesic, Galt Pharmaceuticals, LLC, effective January 8, 2026. Read the full label on DailyMed →
When Orphenadrine citrate, aspirin and caffeine should not be used
Quoted from the “Contraindications” section of the FDA-approved label.
Because of the mild anticholinergic effect of orphenadrine, Norgesic TM Tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy or obstructions at the bladder neck. Norgesic TM Tablets are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. The drug is contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.
— FDA label: Norgesic, Galt Pharmaceuticals, LLC, effective January 8, 2026. Read the full label on DailyMed →
Forms and how it is given
| Dosage forms | Tablet · Tablet, multilayer |
|---|---|
| Route | Oral |
| Prescription products | 5 in the FDA NDC Directory |
| Brand names | Norgesic, Norgesic Forte, Orphengesic Forte |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Galt Pharmaceuticals, LLC2 products
- Atland Pharmaceuticals, LLC2 products
- Poly Pharmaceuticals, Inc.1 product
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (1)
- ANDA075141Galt Pharms · May 29, 1998
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
Next steps
- Find a pharmacy near youAsk which price applies to you and whether your product is affected by a recall
- Latest FDA drug recallsAll medicines, newest first
- NorgesicBrand page: products, maker and price
- Norgesic ForteBrand page: products, maker and price
- Orphengesic ForteBrand page: products, maker and price
- Galt Pharmaceuticals, LLCMaker or distributor
- Atland Pharmaceuticals, LLCMaker or distributor
- Poly Pharmaceuticals, Inc.Maker or distributor
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Norgesic, Galt Pharmaceuticals, LLC, effective January 8, 2026; via openFDA, FDA data exported November 13, 2026, retrieved November 14, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →